Related Experiment Video
Updated: Jun 16, 2026
10:14
Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
Age-related macular degeneration
Wei Wang1, Douglas C Dean, Henry J Kaplan
1Department of Ophthalmology, University of Louisville, Louisville, Kentucky 40202, USA.
Discovery Medicine
|January 28, 2010
Summary
Age-related Macular Degeneration (AMD) causes vision loss, driven by retinal pigment epithelium (RPE) and photoreceptor cell damage. Maculoplasty combines cell therapy with surgical repair for potential vision restoration.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Cell Biology
Background:
- Age-related Macular Degeneration (AMD) is a leading cause of vision loss in individuals over 50.
- The pathogenesis of AMD is not fully understood, despite links to the complement cascade.
- AMD involves the loss of retinal pigment epithelium (RPE) and foveal photoreceptors in the macula.
Purpose of the Study:
- To explore potential therapeutic strategies for Age-related Macular Degeneration (AMD).
- To address the challenges posed by aging-related changes in Bruch's membrane for cell replacement therapy.
Main Methods:
- Generating RPE and photoreceptor cells from stem cells in culture.
- Investigating the role of aging changes in Bruch's membrane.
- Proposing a combined surgical and cell transplantation approach.
Main Results:
- Stem cell-derived RPE and photoreceptors offer hope for cell replacement therapy.
- Aging-induced alterations in Bruch's membrane may impede cell survival and function.
- Surgical reconstruction of macular architecture is proposed as a necessary adjunct.
Conclusions:
- Cell replacement therapy holds promise for AMD treatment.
- Surgical repair of Bruch's membrane is crucial for successful cell transplantation.
- Maculoplasty, a combined approach, is presented as a novel therapeutic strategy for AMD.
More Related Videos
Related Concept Videos
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:22Photoreceptors and Visual Pathways
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.